ArticleJournal of immunology (Baltimore, Md. : 1950)2008

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.

Moniek A de Witte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.